Association of dietary vitamin C intake during pregnancy with preeclampsia and its clinical subtypes
-
摘要:
目的 探讨孕期膳食维生素C摄入与子痫前期(preeclampsia,PE)及其临床亚型的关系。 方法 选取2012年3月1日—2016年9月30日于山西医科大学第一医院妇产科住院分娩的孕妇为研究对象,其中861例PE孕妇作为病例组,7 987例非PE孕妇作为对照组,收集其一般人口学特征、疾病史、家族史及孕期膳食摄入情况等。采用非条件logistic回归分析模型分析孕期膳食维生素C摄入对PE及其临床亚型的发生风险的影响。 结果 调整孕妇年龄、文化程度等影响因素后,孕妇孕早期膳食维生素C摄入达到Q3水平(OR=0.80, 95% CI: 0.64~0.99)、孕晚期达到Q3水平(OR=0.78, 95% CI: 0.63~0.97)会降低PE的发生风险。按照孕前BMI进行分层后,孕前BMI < 24.0 kg/m2的孕妇孕早期膳食维生素C摄入达到Q3水平(OR=0.73, 95% CI: 0.55~0.96)、孕中期达到Q3水平(OR=0.71, 95% CI: 0.54~0.93)、孕晚期达到Q3水平(OR=0.67, 95% CI: 0.51~0.88)是PE的保护因素。进一步探讨不同孕前BMI孕妇膳食维生素C摄入与PE临床亚型的关系后发现,孕前BMI < 24.0 kg/m2的孕妇孕晚期膳食维生素C摄入达到Q3水平(OR=0.66, 95% CI: 0.47~0.93)会降低晚发型子痫前期(late-onset preeclampsia, LOPE)的发生风险。 结论 孕前BMI < 24.0 kg/m2的孕妇Q3水平的膳食维生素C摄入可降低PE的发生风险,尤其是对于LOPE。 Abstract:Objective To investigate the relationship between dietary vitamin C intake during pregnancy and preeclampsia (PE) and its clinical subtypes. Methods Pregnant women who were delivered in the Department of Obstetrics and Gynecology of the First Hospital of Shanxi Medical University from March 1, 2012 to September 30, 2016 were selected as the research subjects. Among them, 861 PE pregnant women were used as the case group and 7 987 non-PE pregnant women were used as the control group. Information on demographic characteristics, disease history, family history and dietary intake during pregnancy were collected. Unconditional logistic regression was used to analyze the influence of dietary vitamin C intake during pregnancy on the risk of PE and its clinical subtypes. Results After adjusting for maternity age, educational level and other influencing factors, the dietary vitamin C intake of pregnant women reached Q3 level in the first trimester (OR=0.80, 95% CI: 0.64-0.99) and the third trimester (OR=0.78, 95% CI: 0.63-0.97) were negatively related with the risk of PE. After stratifying according to the pre-pregnancy BMI, the dietary vitamin C intake of pregnant women with pre-pregnancy BMI < 24.0 kg/m2 reached Q3 level in the first trimester (OR=0.73, 95% CI: 0.55-0.96), the second trimester (OR=0.71, 95% CI: 0.54-0.93) and the third trimester (OR=0.67, 95% CI: 0.51-0.88) were protective factors for PE. After further exploring the relationship between dietary vitamin C intake of pregnant women with different pre-pregnancy BMI and PE clinical subtypes, it was found that the dietary vitamin C intake of pregnant women with pre-pregnancy BMI < 24.0 kg/m2 Q3 level in the third trimester (OR=0.66, 95% CI: 0.47-0.93) reduced risk of late-onset preeclampsia (LOPE). Conclusion Dietary vitamin C intake of pregnant women with Pre-pregnancy BMI < 24.0 kg/m2 at Q3 level had reduced risk of PE, especially for LOPE. -
Key words:
- Vitamin C /
- Preeclampsia /
- Body mass index /
- Late-onset preeclampsia
-
表 1 病例组与对照组孕妇基本特征比较[n(%)]
Table 1. Comparison of the basic characteristics of pregnant women between the case group and the control group [n(%)]
变量 总例数(N=8 848) 病例组(n=861) 对照组(n=7 987) χ2值 P值 孕妇年龄(岁) 1.69 a 0.194 < 25 947(10.70) 140(16.26) 807(10.10) 25~ < 30 4 004(45.25) 333(38.68) 3 671(45.96) ≥30 3 897(44.05) 388(45.06) 3 509(43.94) 文化程度 317.41 a < 0.001 初中及以下 1 529(17.28) 321(37.28) 1 208(15.13) 高中/中专/大专 3 101(35.05) 339(39.37) 2 762(34.58) 大学及以上 4 218(47.67) 201(23.35) 4 017(50.29) 孕前BMI (kg/m2) 149.85 a < 0.001 < 18.5 1 188(13.43) 62(7.20) 1 126(14.10) 18.5~ < 24.0 5 950(67.25) 494(57.38) 5 456(68.31) ≥24.0 1 710(19.32) 305(35.42) 1 405(17.59) 居住地 371.25 < 0.001 城市 6 872(77.67) 445(51.68) 6 427(80.47) 农村 1 976(22.33) 416(48.32) 1 560(19.53) 人均月收入(元) 119.88 a < 0.001 < 2 000 1 468(16.59) 237(27.53) 1 231(15.41) 2 000~ < 4 000 4 982(56.31) 497(57.72) 4 485(56.15) ≥4 000 2 398(27.10) 127(14.75) 2 271(28.44) 孕前健康教育 97.11 < 0.001 是 3 353(37.90) 193(22.42) 3 160(39.56) 否 5 495(62.10) 668(77.58) 4 827(60.44) 孕期被动吸烟 21.32 < 0.001 是 1 166(13.18) 157(18.23) 1 009(12.63) 否 7 682(86.82) 704(81.77) 6 978(87.37) 孕期体育活动 3.54 0.060 是 8 244(93.17) 789(91.64) 7 455(93.34) 否 604(6.83) 72(8.36) 532(6.66) 孕期增重 75.21 a < 0.001 不足 1 523(17.21) 108(12.54) 1 415(17.72) 适宜 3 552(40.15) 258(29.97) 3 294(41.24) 过多 3 773(42.64) 495(57.49) 3 278(41.04) 产次 17.78 < 0.001 初产 6 647(75.12) 596(69.22) 6 051(75.76) 经产 2 201(24.88) 265(30.78) 1 936(24.24) 妊娠期糖尿病 9.15 0.003 是 1 306(14.76) 157(18.23) 1 149(14.39) 否 7 542(85.24) 704(81.77) 6 838(85.61) 高血压家族史 59.81 < 0.001 是 1 409(15.92) 216(25.09) 1 193(14.94) 否 7 439(84.08) 645(74.91) 6 794(85.06) 膳食维生素C摄入(mg/d) 15.90 a < 0.001 Q1 (< 84.30) 2 270(25.66) 274(31.82) 1 996(24.99) Q2 (84.30~ < 101.82) 2 203(24.90) 207(24.04) 1 996(24.99) Q3 (101.82~ < 127.25) 2 192(24.77) 193(22.42) 1 999(25.03) Q4 (≥127.25) 2 183(24.67) 187(21.72) 1 996(24.99) 注:a表示进行秩和检验的χ2值。 表 2 孕妇膳食维生素C摄入与PE关系的非条件logistic回归分析
Table 2. Unconditional logistic regression analysis of the relationship between dietary vitamin C intake and PE in pregnant women
维生素C摄入(mg/d) 病例人数/对照人数 OR(95% CI)值 OR(95% CI)值a 孕早期 Q1 (< 84.06) 276/1 996 1.00 1.00 Q2 (84.06~ < 101.82) 208/1 983 0.76(0.63~0.92) 0.93(0.75~1.15) Q3 (101.82~ < 127.34) 189/2 011 0.68(0.56~0.83) 0.80(0.64~0.99) Q4 (≥127.34) 188/1 998 0.68(0.56~0.83) 0.90(0.69~1.16) 孕中期 Q1 (< 84.28) 275/1 997 1.00 1.00 Q2 (84.28~ < 102.18) 208/1 997 0.76(0.63~0.92) 0.92(0.75~1.14) Q3 (102.18~ < 127.75) 189/1 997 0.69(0.57~0.84) 0.82(0.66~1.02) Q4 (≥127.75) 189/1 996 0.69(0.57~0.84) 0.92(0.71~1.20) 孕晚期 Q1 (< 83.84) 279/1 995 1.00 1.00 Q2 (83.84~ < 102.06) 210/1 998 0.75(0.62~0.91) 0.91(0.73~1.12) Q3 (102.06~ < 127.61) 184/1 998 0.66(0.54~0.80) 0.78(0.63~0.97) Q4 (≥127.61) 188/1 996 0.67(0.55~0.82) 0.88(0.68~1.14) 注:a调整因素包括孕妇年龄、文化程度、孕前BMI、居住地、人均月收入、孕前健康教育、孕期被动吸烟、孕期增重、产次、妊娠期糖尿病、高血压家族史、总能量摄入。 表 3 不同孕前BMI孕妇膳食维生素C摄入与PE关系的非条件logistic回归分析
Table 3. Unconditional logistic regression analysis of the relationship between dietary vitamin C intake and PE in pregnant women with different pre-pregnancy BMI
维生素C摄入(mg/d) BMI < 24.0 kg/m2 BMI≥24.0 kg/m2 交互作用P值 病例人数/对照人数 OR(95% CI)值a 病例人数/对照人数 OR(95% CI)值a 孕早期 < 0.001 Q1 (< 84.06) 177/1 600 1.00 99/396 1.00 Q2 (84.06~ < 101.82) 131/1 643 0.84(0.65~1.09) 77/340 1.18(0.81~1.72) Q3 (101.82~ < 127.34) 110/1 643 0.73(0.55~0.96) 79/368 1.01(0.69~1.47) Q4 (≥127.34) 138/1 696 0.89(0.65~1.20) 50/301 0.94(0.57~1.54) 孕中期 < 0.001 Q1 (< 84.28) 177/1 597 1.00 98/400 1.00 Q2 (84.28~ < 102.18) 134/1 646 0.86(0.66~1.11) 74/351 1.10(0.75~1.62) Q3 (102.18~ < 127.75) 108/1 642 0.71(0.54~0.93) 81/355 1.16(0.79~1.69) Q4 (≥127.75) 137/1 697 0.88(0.65~1.19) 52/299 1.06(0.64~1.74) 孕晚期 < 0.001 Q1 (< 83.84) 179/1 592 1.00 100/403 1.00 Q2 (83.84~ < 102.06) 135/1 651 0.83(0.64~1.07) 75/347 1.11(0.76~1.62) Q3 (102.06~ < 127.61) 105/1 640 0.67(0.51~0.88) 79/358 1.11(0.76~1.62) Q4 (≥127.61) 137/1 699 0.84(0.62~1.14) 51/297 0.99(0.61~1.63) 注:a调整因素包括孕妇年龄、文化程度、居住地、人均月收入、孕前健康教育、孕期被动吸烟、孕期增重、产次、妊娠期糖尿病、高血压家族史、总能量摄入。 表 4 不同孕前BMI孕妇不同时期维生素C摄入量与PE临床亚型的关系
Table 4. The relationship between vitamin C intake and PE clinical subtypes in pregnant women with different pre-pregnancy BMI
维生素C摄入(mg/d) 对照组(n=7 987) EOPE(n=376) EOPE OR(95% CI)值a LOPE(n=485) LOPE OR(95% CI)值a BMI < 24.0 kg/m2 孕早期 Q1 (< 84.06) 1 600(24.31) 74(30.96) 1.00 103(32.49) 1.00 Q2 (84.06~ < 101.82) 1 643(24.96) 53(22.18) 0.88(0.60~1.30) 78(24.61) 0.83(0.60~1.14) Q3 (101.82~ < 127.34) 1 643(24.96) 45(18.83) 0.77(0.51~1.16) 65(20.50) 0.71(0.50~1.00) Q4 (≥127.34) 1 696(25.77) 67(28.03) 1.14(0.73~1.77) 71(22.40) 0.76(0.51~1.12) 孕中期 Q1 (< 84.28) 1 597(24.26) 73(30.54) 1.00 104(32.81) 1.00 Q2 (84.28~ < 102.18) 1 646(25.01) 59(24.69) 0.99(0.68~1.44) 75(23.66) 0.79(0.57~1.10) Q3 (102.18~ < 127.75) 1 642(24.95) 42(17.57) 0.72(0.47~1.09) 66(20.82) 0.71(0.50~1.01) Q4 (≥127.75) 1 697(25.78) 65(27.20) 1.10(0.71~1.72) 72(22.71) 0.76(0.51~1.13) 孕晚期 Q1 (< 83.84) 1 592(24.19) 72(30.13) 1.00 107(33.75) 1.00 Q2 (83.84~ < 102.06) 1 651(25.08) 60(25.10) 0.99(0.68~1.44) 75(23.66) 0.74(0.54~1.03) Q3 (102.06~ < 127.61) 1 640(24.92) 41(17.15) 0.70(0.46~1.07) 64(20.19) 0.66(0.47~0.93) Q4 (≥127.61) 1 699(25.81) 66(27.62) 1.13(0.72~1.76) 71(22.40) 0.70(0.47~1.04) BMI≥24.0 kg/m2 孕早期 Q1 (< 84.06) 396(28.19) 40(29.20) 1.00 59(35.11) 1.00 Q2 (84.06~ < 101.82) 340(24.20) 34(24.82) 1.21(0.71~2.04) 43(25.60) 1.11(0.69~1.80) Q3 (101.82~ < 127.34) 368(26.19) 36(26.28) 1.02(0.60~1.72) 43(25.60) 0.95(0.58~1.53) Q4 (≥127.34) 301(21.42) 27(19.71) 1.20(0.62~2.30) 23(13.69) 0.73(0.37~1.43) 孕中期 Q1 (< 84.28) 400(28.47) 41(29.92) 1.00 57(33.93) 1.00 Q2 (84.28~ < 102.18) 351(24.98) 32(23.36) 1.02(0.60~1.73) 42(25.00) 1.13(0.70~1.84) Q3 (102.18~ < 127.75) 355(25.27) 38(27.74) 1.14(0.68~1.92) 43(25.59) 1.14(0.70~1.87) Q4 (≥127.75) 299(21.28) 26(18.98) 1.13(0.58~2.18) 26(15.48) 0.99(0.52~1.93) 孕晚期 Q1 (< 83.84) 403(28.68) 41(29.92) 1.00 59(35.12) 1.00 Q2 (83.84~ < 102.06) 347(24.70) 33(24.09) 1.09(0.65~1.83) 42(25.00) 1.09(0.67~1.76) Q3 (102.06~ < 127.61) 358(25.48) 38(27.74) 1.14(0.68~1.92) 41(24.40) 1.05(0.65~1.72) Q4 (≥127.61) 297(21.14) 25(18.25) 1.08(0.57~2.07) 26(15.48) 0.93(0.49~1.76) 注:a调整因素包括孕妇年龄、文化程度、居住地、人均月收入、孕前健康教育、孕期被动吸烟、孕期增重、产次、妊娠期糖尿病、高血压家族史、总能量摄入。 -
[1] Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia[J]. Lancet, 2016, 387(10022): 999-1011. DOI: 10.1016/S0140-6736(15)00070-7. [2] MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia[J]. Obstet Gynecol, 2001, 97(4): 533-538. DOI: 10.1016/s0029-7844(00)01223-0. [3] Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2013, 170(1): 1-7. DOI: 10.1016/j.ejogrb.2013.05.005. [4] Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspective[J]. Circ Res, 2019, 124(7): 1094-1112. DOI: 10.1161/CIRCRESAHA.118.313276. [5] Grotegut CA. Prevention of preeclampsia[J]. J Clin Investig, 2016, 126(12): 4396-4398. DOI: 10.1172/jci91300. [6] Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications[J]. Semin Nephrol, 2017, 37(4): 386-397. DOI: 10.1016/j.semnephrol.2017.05.011. [7] Schwartz A, Many A, Shapira U, et al. Perinatal outcomes of pregnancy in the fifth decade and beyond-a comparison of very advanced maternal age groups[J]. Sci Rep, 2020, 10(1): 1809. DOI: 10.1038/s41598-020-58583-6. [8] Santos S, Voerman E, Amiano P, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts[J]. BJOG, 2019, 126(8): 984-995. DOI: 10.1111/1471-0528.15661. [9] Muto H, Yamamoto R, Ishii K, et al. Risk assessment of hypertensive disorders in pregnancy with maternal characteristics in early gestation: a single-center cohort study[J]. Taiwan J Obstet Gyneco, 2016, 55(3): 341-345. DOI: 10.1016/j.tjog.2016.04.009. [10] Cardoso PM, Surve S. The effect of vitamin E and vitamin C on the prevention of preeclampsia and newborn outcome: a case-control study[J]. J Obstet Gynaecol India, 2016, 66(Suppl 1): 271-278. DOI: 10.1007/s13224-016-0885-z. [11] Rumbold A, Ota E, Nagata C, et al. Vitamin C supplementation in pregnancy[J]. Cochrane Database Syst Rev, 2015, 2015(9): CD004072. DOI: 10.1002/14651858.CD004072.pub3. [12] Shao YW, Qiu J, Huang H, et al. Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China[J]. BMC Pregnancy Childbirth, 2017, 17(1): 400. DOI:10.1186/s12884-017-1567-2. Ethn Health S [13] Canto-Cetina T, Coral-Vázquez RM, Rojano-Mejía D, et al. Higher prepregnancy body mass index is a risk factor for developing preeclampsia in Maya-Mestizo women: a cohort study[J]. Ethn Health, 2018, 23(6): 682-690. DOI: 10.1080/13557858.2017.1315367. [14] Vioque J, Weinbrenner T, Asensio L, et al. Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects[J]. Br J Nutr, 2007, 97(5): 977-986. DOI: 10.1017/s0007114507659017. [15] 杨孜, 张为远. 妊娠期高血压疾病诊治指南(2015)[J]. 中华产科急救电子杂志, 2015, 4(4): 206-213. DOI: 10.3877/cma.J.issn.2095-3259.2015.04.004.Yang Z, Zhang WY. Guidelines for diagnosis and treatment of hypertensive disorders in pregnancy (2015)[J]. Chin J Obstet Emerg (Electronic Edition), 2015, 4(4): 206-213. DOI: 10.3877/cma.J.issn.2095-3259.2015.04.004. [16] Wang Y, Zhao N, Qiu J, et al. Folic acid supplementation and dietary folate intake, and risk of preeclampsia[J]. Eur J Clin Nutr, 2015, 69(10): 1145-1150. DOI: 10.1038/ejcn.2014.295. [17] 中国肥胖问题工作组数据汇总分析协作组. 我国成人体重指数和腰围对相关疾病危险因素异常的预测价值: 适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志, 2002, 23(1): 5-10. DOI: 10.3760/j.issn:0254-6450.2002.01.003.Coorperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J]. Chin J Epidemiol, 2002, 23(1): 5-10. DOI: 10.3760/j.issn:0254-6450.2002.01.003. [18] Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis[J]. BMJ, 2013, 347: f6564. DOI: 10.1136/bmj.f6564. [19] Saleem S, McClure EM, Goudar SS, et al. A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries[J]. Bull World Health Organ, 2014, 92(8): 605-612. DOI: 10.2471/BLT.13.127464. [20] Yusrawati, Saputra NPK, Lipoeto NI, et al. Analyses of nutrients and body mass index as risk factor for preeclampsia[J]. J Obstet Gynaecol India, 2017, 67(6): 409-413. DOI: 10.1007/s13224-017-0982-7. [21] Zhang CL, Williams MA, King IB, et al. Vitamin C and the risk of preeclampsia: results from dietary questionnaire and plasma assay[J]. Epidemiology, 2002, 13(4): 409-416. DOI: 10.1097/00001648-200207000-00008. [22] Klemmensen A, Tabor A, Osterdal ML, et al. Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study among 57 346 women[J]. BJOG, 2009, 116(7): 964-974. DOI: 10.1111/j.1471-0528.2009.02150.x. [23] Mutinati M, Piccinno M, Roncetti M, et al. Oxidative stress during pregnancy in the sheep[J]. Reprod Domest Anim, 2013, 48(3): 353-357. DOI: 10.1111/rda.12141. [24] Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial[J]. Lancet, 2006, 367(9517): 1145-1154. DOI: 10.1016/s0140-6736(06)68433-x. [25] Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans[J]. Proc Natl Acad Sci U S A, 2009, 106(21): 8665-8670. DOI: 10.1073/pnas.0903485106. [26] Kala M, Shaikh MV, Nivsarkar M. Equilibrium between anti-oxidants and reactive oxygen species: a requisite for oocyte development and maturation[J]. Reprod Med Biol, 2016, 16(1): 28-35. DOI: 10.1002/rmb2.12013. [27] Phipps EA, Thadhani R, Benzing T, et al. Pre-eclampsia: pathogenesis, novel diagnostics and therapies[J]. Nat Rev Nephrol, 2019, 15(5): 275-289. DOI: 10.1038/s41581-019-0119-6. [28] Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials[J]. Hypertension, 2004, 44(4): 374-380. DOI: 10.1161/01.HYP.0000141085.98320.01. [29] Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia[J]. Semin Reprod Endocrinol, 1998, 16(1): 93-104. DOI: 10.1055/s-2007-1016256. [30] Conde-Agudelo A, Romero R, Kusanovic JP, et al. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2011, 204(6): 503. DOI: 10.1016/j.ajog.2011.02.020. [31] Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial[J]. Lancet, 1999, 354(9181): 810-816. DOI: 10.1016/S0140-6736(99)80010-5. [32] Mandl J, Szarka A, Bánhegyi G. Vitamin C: update on physiology and pharmacology[J]. Br J Pharmacol, 2009, 157(7): 1097-1110. DOI: 10.1111/j.1476-5381.2009.00282.x. [33] Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients[J]. Faseb J, 1987, 1(6): 441-445. DOI: 10.1096/fasebj.1.6.3315807. [34] Robillard PY, Dekker G, Scioscia M, et al. Increased BMI has a linear association with late-onset preeclampsia: a population-based study[J]. PLoS One, 2019, 14(10): e0223888. DOI: 10.1371/journal.pone.0223888. [35] Örgül G, HaklI DA, Özten G, et al. First trimester complete blood cell indices in early and late onset preeclampsia[J]. Turk J Obstet Gynecol, 2019, 16(2): 112-117. DOI: 10.4274/tjod.galenos.2019.93708.